Assessment of coronary artery diseases in 2007

Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective

I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis

M3: Managing the Cardiometabolic Risk in MASH

Maximizing Adherence and Persistence via Patient Engagement

Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)

HF Management for Patients with Comorbid Conditions

Level Up Your Skills: Tailoring Management of HF

Navigating Myasthenia Gravis in Adolescents and Young Adults